Results 61 to 70 of about 593 (81)

Advancing optogenetic therapies for retinal diseases: a regulatory vision

Cell and Gene Therapy Insights
“We are at an exciting stage in our drug development program, and I am committed to advancing Nanoscope’s mission, driving regulatory success, and supporting our pipeline’s growth.” Jokūbas Leikauskas, Editor, Cell & Gene Therapy Insights, speaks to ...
A. Ayyagari
semanticscholar   +1 more source

From innovation to access: bridging gaps in scalability and cold chain precision logistics for advanced therapies

Cell and Gene Therapy Insights
Rohin Iyer, Senior Director, Global Cell and Gene Therapy Operations, Marken, speaks to Jokūbas Leikauskas, Editor, BioInsights, about addressing the complex logistics of cell and gene therapies through global infrastructure, precision, and advanced ...
R. Iyer
semanticscholar   +1 more source

Advancing nucleic acid therapeutics with circular RNA

Nucleic Acid Insights
“...the key realization is that optimizing each component individually...is necessary but not sufficient.”In this podcast episode, Jokūbas Leikauskas, Editor, BioInsights, speaks to Trevor Hallam, who served as Chief Scientific Officer of Sail ...
T. Hallam
semanticscholar   +1 more source

Optimizing upstream processing to improve consistency and scalability in viral vector production

Cell and Gene Therapy Insights
“It is exciting to build something from an early stage...and getting to enjoy the results of that work.”Jokūbas Leikauskas, Editor, BioInsights, speaks to Katerina Rigaki, Upstream Manager PD Vector, Autolus Therapeutics, about overcoming the technical ...
Katerina Rigaki
semanticscholar   +1 more source

Exploring innovations in AAV upstream processing to advance gene therapy development

Cell and Gene Therapy Insights
“...my goal is to introduce innovative designs and new concepts to the AAV manufacturing field.” Jokūbas Leikauskas, Editor, Cell & Gene Therapy Insights, speaks to Hao Liu, Viral Vector Core Research Associate III, Horae Gene Therapy Center, UMass Chan ...
Hao Liu
semanticscholar   +1 more source

Exploring translational challenges and strategies for advancing gene therapies in neurodegenerative diseases

Cell and Gene Therapy Insights
Jokūbas Leikauskas, Editor, BioInsights, speaks to Joseph Scarrott, Process Development/R&D Lead, Gene Therapy Innovation and Manufacturing Centre (GTIMC) at the University of Sheffield, about translational gene therapies for neurodegenerative diseases ...
Joseph Scarrott
semanticscholar   +1 more source

Outsmarting immune aging: designing vaccines for older adults

Vaccine Insights
“It is essential to effectively communicate the benefits of vaccination, especially for the aging population...”Jokūbas Leikauskas, Editor, BioInsights, speaks to Birgit Weinberger, Head of Institute for Biomedical Aging Research, University of Innsbruck,
Birgit Weinberger
semanticscholar   +1 more source

Building trust in vaccines: why emotions are as important as facts

Vaccine Insights
“I think some of the biggest recurring challenges we face in science communication...all have significant roots in people’s feelings about science and technology.” Jokūbas Leikauskas (Editor, BioInsights) speaks to Stephen Hughes (Lecturer, Department of
Stephen R Hughes
semanticscholar   +1 more source

Regulatory innovations: why is the UK an attractive hub for CGT development?

Cell and Gene Therapy Insights
“...the UK has representation in nearly 50% of all European ATMP trials” Jokūbas Leikauskas, Editor, BioInsights, speaks to Rehma Chandaria, Senior Regulatory Affairs Lead, Cell and Gene Therapy Catapult, about the UK’s position as an attractive hub for ...
Rehma Chandaria
semanticscholar   +1 more source

Exploring the UK’s evolving role in commercializing cell and gene therapies

Cell and Gene Therapy Insights
“...the UK is strongly behind cell and gene therapy, and we have an excellent regulatory agency...” Jokūbas Leikauskas, Editor, BioInsights, speaks to Matthew Durdy, CEO, Cell and Gene Therapy Catapult, about addressing key barriers to cell and gene ...
Matthew B Durdy
semanticscholar   +1 more source